LNPs (Lipid Nanoparticles) are a type of liposomal drug delivery system that is composed of a lipid core surrounded by a phospholipid bilayer. Like other liposomes, LNPs are capable of encapsulating a wide range of drugs, including small molecules, proteins, and nucleic acids, and they offer several advantages over traditional drug delivery systems, including targeted delivery, increased stability, enhanced bioavailability, and reduced toxicity. One key advantage of LNPs is their ability to be formulated in a variety of sizes and shapes, which allows them to be tailored for specific drug delivery applications. LNPs can be formulated as small, uniform nanoparticles that are suitable for intravenous or intranasal delivery, or they can be formulated as larger, multilamellar vesicles that are suitable for oral or topical delivery. In addition to their versatility, LNPs are generally considered to be a safe and effective drug delivery system, with low toxicity and a high drug loading capacity. They have been used in a variety of clinical trials and have shown promise in the delivery of a wide range of drugs, including small molecules, proteins, and nucleic acids.
At HTD, we have expertise in the development of LNPs for drug delivery applications. Our team of scientists is skilled in the design and optimization of LNPs for specific drugs and indications, and we are dedicated to supporting the development of safe and effective LNP-based drug delivery systems.
Contact Us Today
HTD has worked and collaborated with many companies, governments, and academia.
About us HTD is a private company located in Livermore, California. HTD has worked and collaborated with other companies, governments, and academia. Our researchers have helped other companies develop their products.